RAD Receives Expansion Order from Global Small Box Retailer

New Post Public Reply Private Reply Replies (0) Message Board
Ulf53
250
RAD Receives Expansion Order from Global Small Box Retailer and Major Power Utility

Detroit, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the Company) (OTCPK:AITX), today announced that its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD) has been notified by the Company's largest authorized dealer that an existing small box retailer continues to expand their RAD deployments. This order is for 5 ROSA security robots. Also received from this dealer is an order for 1 AVA secure access control device for a top five utility company.


"ROSA and AVA continue to make their mark in the security industry," said Mark Folmer, President of RAD. "Once a corporate end user discovers what they can do, how affordable they are, and how they are able to reassign or reduce their reliance on human guards, we're in. We appreciate this great dealer of ours for communicating this value proposition so effectively."

"There's a great quote by Henry Ford," commented Steve Reinharz, CEO of AITX and RAD. "He said 'most people spend more time and energy going around problems than in trying to solve them', how true. At RAD we're all about solving problems. These great orders, to be deployed at two amazing end users will solve their problems, at a price dramatically lower than a manned guarding option. Plus, I'm excited that this week we begin shipping ROSA 3.1, loaded with upgrades like enhanced audio and brighter lights and visuals, all powered by RAD-G's RADPack."

ROSA is a multiple award-winning, compact, self-contained, portable, security and communication solution that can be deployed in about 15 minutes. Like other RAD solutions, a stand-alone ROSA only requires power, which is provided when configured along with RIO, as it includes all necessary communications hardware. ROSA's AI-driven security analytics include human, firearm, vehicle detection, license plate recognition, responsive digital signage and audio messaging, and complete integration with RAD's software suite notification and autonomous response library. Two-way communication is optimized for cellular, including live video from ROSA's dual high-resolution, full-color, always-on cameras. RAD has published two Case Studies detailing how ROSA has helped eliminate instances of theft, trespassing and loitering at car rental locations and construction sites across the country.

AVA (Autonomous Verified Access) is a compact and stanchion mountable unit that provides an edge-to-edge 180° field of vision with advanced access control over gates and other controlled points of entry. AVA takes full advantage of the RAD Software Suite providing an ideal solution for gated communities, logistics and distribution centers, storage yards, parking structures and lots, corporate campuses; anywhere that increased security and visibility is needed at a fraction of the cost. At ISC West in late March, AVA was named a winner of the 2022 SIA New Products and Solutions Awards in the category of Access Control Software, Hardware, Devices and Peripherals.

RAD has a sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.

RAD's parent company AITX has filed for uplisting to the OTCQB. Future announcements will be made regarding the status of the OTCQB application.

Read More: https://investorshangout.com/post/view?id=649...z7jxTiebsl
Robert
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading